首页> 外文会议>ASME summer bioengineering conference;SBC2012 >TOWARDS A BIOMECHANICALLY-BASED DIAGNOSIS FOR GLAUCOMA: IN VIVO DEFORMATION MAPPING OF THE HUMAN OPTIC NERVE HEAD
【24h】

TOWARDS A BIOMECHANICALLY-BASED DIAGNOSIS FOR GLAUCOMA: IN VIVO DEFORMATION MAPPING OF THE HUMAN OPTIC NERVE HEAD

机译:迈向基于生物力学的青光眼诊断:人体视神经头的体内变形映射

获取原文

摘要

Glaucoma is the most common cause of irreversible blindness. It is associated with a progressive loss of cells within the optic nerve head (ONH) at the back of the eye. Glaucoma remains incurable and its exact causes are not well understood. It was once thought to occur only in eyes with elevated pressure (i.e., intraocular pressure or IOP) and to date, lowering IOP is the only clinical treatment proven to be beneficial for slowing the progression of glaucoma. However, the success rate of such therapy is only 50%. Multiple lines of evidence now indicate that IOP is not the only important risk factor in the disease. For instance, while some patients develop glaucoma at elevated IOP (high-tension glaucoma), some develop glaucoma at normal IOP levels (normal-tension glaucoma), and some others with elevated IOP do not develop glaucoma at all.
机译:青光眼是不可逆性失明的最常见原因。它与眼后部视神经头(ONH)内的细胞逐渐丢失有关。青光眼仍然是无法治愈的,其确切原因还没有被很好地理解。曾经认为它仅发生在眼压升高(即眼内压或IOP)的眼中,迄今为止,降低IOP是唯一被证明对减缓青光眼进展有益的临床治疗方法。但是,这种疗法的成功率仅为50%。现在有多种证据表明,眼压不是该疾病的唯一重要危险因素。例如,虽然一些患者在IOP升高时发生青光眼(高压青光眼),但有些患者在IOP正常水平时发展为青光眼(正常血压的青光眼),而另一些IOP升高的患者则根本不发展青光眼。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号